Firm at a glance
NMS Capital is a platform private equity firm founded in 2010 and headquartered in New York, NY, per its own website [S1].
What they buy
NMS Capital’s portfolio reflects a focus on two primary sectors: healthcare services and business services [S2]. The firm has established platform investments in dermatology, behavioral health, dental, autism services, and specialty consulting, suggesting a pattern of acquiring founder-led service businesses with fragmented market structures [S2]. The firm maintains offices in both New York and Dallas [S1].
Portfolio
Healthcare Services
Platform investments in this sector include Anne Arundel Dermatology (acquired 2015), Constellation Behavioral Health (acquired 2016), CORDENTAL Group (acquired 2017), and CSD Autism Services (acquired 2019) [S2]. The firm added DCM BioServices as an add-on acquisition in June 2026 [S3].
Business Services
The firm’s business services platforms include Avaap (acquired 2016), Capstone Mechanical (acquired 2025), and CSL Consulting (acquired 2024) [S2]. Diamond Back Landfill was acquired as an add-on in January 2026 [S3].
Recent activity (last 24 months)
* **June 2026**: Add-on acquisition of DCM BioServices [S3]
* **January 2026**: Add-on acquisition of Diamond Back Landfill [S3]
* **2025**: Platform acquisition of Capstone Mechanical [S2]
* **2024**: Platform acquisition of CSL Consulting [S2]
How this firm fits a seller
NMS Capital appears to pursue a buy-and-build strategy, evidenced by two add-on acquisitions in the trailing twelve months alongside platform investments [S2][S3]. The firm’s portfolio composition suggests suitability for owner-operators in fragmented healthcare and business services markets where consolidation opportunities exist. Sellers in dermatology, behavioral health, dental, autism services, mechanical contracting, or specialized consulting may find sector alignment with existing platforms [S2]. The firm’s activity through mid-2026 indicates ongoing deployment.
Sources
[S1] https://nms-capital.com (as of 2026-01-15)
[S2] https://nms-capital.com/portfolio (as of 2026-01-15)
[S3] https://nms-capital.com/news (as of 2026-01-15)
Frequently asked questions
Does NMS Capital buy Healthcare Services businesses?
Yes, approximately half of NMS Capital’s disclosed portfolio consists of healthcare services platforms [S2]. The firm has acquired businesses in dermatology, behavioral health, dental, and autism services since 2015, and completed an add-on healthcare acquisition as recently as June 2026 [S2][S3].
What companies has NMS Capital acquired recently?
Recent acquisitions include Capstone Mechanical and CSL Consulting as platform investments in 2025 and 2024 respectively, plus two add-on transactions: Diamond Back Landfill in January 2026 and DCM BioServices in June 2026 [S2][S3].
Where is NMS Capital based and how big is the firm?
NMS Capital is headquartered in New York, NY, with an additional office in Dallas, TX [S1]. Fund size and assets under management were not publicly disclosed in available sources as of January 2026.
Is NMS Capital still actively acquiring?
Yes, the firm completed its most recent disclosed transaction in June 2026 with the add-on acquisition of DCM BioServices [S3]. The firm has completed four transactions in the trailing 24 months, indicating active deployment [S2][S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.